Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes.

Blood Adv · 2025 · PMC12686793 · PMID 40875593

Europe PMC DOI

hedged sentence

0.2800

closest p · 5.6× alpha

0.2800

boldest claim

The sentences

did not reach statistical significanceP = .28not close (p > 0.1)

Among the patients with ECD-C with a BRAF mutation, there was a trend toward improved PFS in those treated with targeted therapy; however, this difference did not reach statistical significance ( P = .28; supplemental Figure 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.